3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 13, 2009
Period of Report: March 4, 2009
Accession Number: 0001325812-09-000003

View Document ↗ View on SEC.gov ↗